These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28537793)

  • 1. In this issue: Role of immune cells, immune modulating factors and immunotoxins in cancer immunotherapy.
    Kumar H; Bot A
    Int Rev Immunol; 2017 Jul; 36(4):205-206. PubMed ID: 28537793
    [No Abstract]   [Full Text] [Related]  

  • 2. A Believer's Overview of Cancer Immunosurveillance and Immunotherapy.
    Finn OJ
    J Immunol; 2018 Jan; 200(2):385-391. PubMed ID: 29311379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor immunology.
    Stevenson HC; Tsang KY
    Immunol Ser; 1990; 50():513-33. PubMed ID: 2091767
    [No Abstract]   [Full Text] [Related]  

  • 4. Cancer immunotherapy and immunomonitoring (CITIM): redefining cancer therapy.
    Malyguine A; Umansky V; Shurin MR
    J Immunotoxicol; 2009 Dec; 6(4):205-8. PubMed ID: 19908938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular mechanisms of tumor and immune system interaction].
    Berezhnoĭ AE; Gnuchev NV; Georgiev GP; Kozlov AM; Larin SS
    Vopr Onkol; 2008; 54(6):669-83. PubMed ID: 19241839
    [No Abstract]   [Full Text] [Related]  

  • 6. Prospects for the immunotherapy of cancer. Part II: current status of immunotherapy.
    Pilch YH; Myers GH; Sparks FC; Golub SH
    Curr Probl Surg; 1975 Feb; ():1-61. PubMed ID: 1092529
    [No Abstract]   [Full Text] [Related]  

  • 7. Radiation-enhanced immune response to cancer: workshop, Anaheim, CA, April 17, 2005.
    Sutherland RM
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):3-5. PubMed ID: 16377408
    [No Abstract]   [Full Text] [Related]  

  • 8. [Oncoimmunology: some fundamental problems of cancer immunotherapy].
    Nedospasov SA; Kuprash DV
    Mol Biol (Mosk); 2007; 41(2):355-68. PubMed ID: 17514902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transferrin receptor 1: a target for antibody-mediated cancer therapy.
    Daniels-Wells TR; Penichet ML
    Immunotherapy; 2016 Sep; 8(9):991-4. PubMed ID: 27373880
    [No Abstract]   [Full Text] [Related]  

  • 10. Epigenetic modifiers in immunotherapy: a focus on checkpoint inhibitors.
    Terranova-Barberio M; Thomas S; Munster PN
    Immunotherapy; 2016 Jun; 8(6):705-19. PubMed ID: 27197539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-13 receptor-directed cancer vaccines and immunotherapy.
    Nakashima H; Husain SR; Puri RK
    Immunotherapy; 2012 Apr; 4(4):443-51. PubMed ID: 22512637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy.
    Vesely MD; Schreiber RD
    Ann N Y Acad Sci; 2013 May; 1284(1):1-5. PubMed ID: 23651186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An introduction to tumour immunology.
    Keith J
    Mater Med Pol; 1984; 16(1):54-64. PubMed ID: 6394909
    [No Abstract]   [Full Text] [Related]  

  • 15. Adequate antigen availability: a key issue for novel approaches to tumor vaccination and tumor immunotherapy.
    Accolla RS; Tosi G
    J Neuroimmune Pharmacol; 2013 Mar; 8(1):28-36. PubMed ID: 23224729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunotherapy of cancer.
    Parker CW
    Pharmacol Rev; 1973 Jun; 25(2):325-42. PubMed ID: 4581047
    [No Abstract]   [Full Text] [Related]  

  • 17. Cancer and the immune system.
    Smith RT
    Pediatr Clin North Am; 1994 Aug; 41(4):841-50. PubMed ID: 8047372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour immunotherapy: the adjuvant treatment of the 21st century?
    Bremers AJ; Kuppen PJ; Parmiani G
    Eur J Surg Oncol; 2000 Jun; 26(4):418-24. PubMed ID: 10873365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer and the Immune System: The History and Background of Immunotherapy.
    Abbott M; Ustoyev Y
    Semin Oncol Nurs; 2019 Oct; 35(5):150923. PubMed ID: 31526550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy for cancer.
    Old LJ
    Sci Am; 1996 Sep; 275(3):136-43. PubMed ID: 8701283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.